Guidelines found and selected, and their score in respect of the criteria used to reach the final choice
| Guideline | AGREE II ratings | Topic | Publication Date | Comprehensiveness (applicability to different settings) | |||||
| Average of key items | |||||||||
| 4 | 7 | 8 | 12 | 22 | 4, 7, 8, 10, 12, 13, 15, 22, 23 | ||||
| NICE—adalimumab26 | 4 | 5 | 3.5 | 6 | 4 | 45.5 | Posterior uveitis | 2017 | Low |
| ACR—JIA uveitis27 | 4 | 6.5 | 5 | 3 | 4 | 45 | JIA uveitis | 2019 | High |
| NICE—uveitis CKS28 | 3.5 | 7 | 5.5 | 6 | 4 | 46.5 | Anterior uveitis | 2019 | High |
| Cincinnati Children’s Hospital Medical Centre. BESt Screening for Uveitis in Children with JIA20 | 3 | 6 | 2 | 5.5 | 3.5 | – | JIA uveitis | 2021 | |
| Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for JIA-Associated and Idiopathic Chronic Anterior Uveitis21 | 3 | 5 | 2 | 1.5 | 3.5 | – | JIA uveitis | 2019 | |
| Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with JIA.22 | 4 | 5 | 2 | 4.5 | 4 | – | JIA uveitis | 2012 | |
| College of Optometrists Clinical Management Guidelines Uveitis (Anterior)23 | 3 | 1.5 | 1 | 2 | 3 | – | Anterior uveitis | 2020 | |
| Document of treatment recommendations for non-infectious anterior uveitis.24 | 3 | 3.5 | 5.5 | 5.5 | 4 | 43 | Anterior uveitis | 2017 | |
| NICE—fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis-guidance (TA590).25 | 4 | 5 | 3 | 6 | 4 | 44.5 | Non-infectious uveitis | 2019 | |
.ACR, American College of Rheumatology; AGREE II, Appraisal of Guidelines for Research and Evaluation II; CKS, clinical knowledge summary; JIA, Juvenile Idiopathic Arthritis; NICE, National Institute for Health and Care Excellence.